Post-discharge outcomes of hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C
© 2024 Fink, Alcamo, Lovett, Hartman, Williams, Garcia, Rasmussen, Pal, Drury, MackDiaz, Ferrazzano, Dervan, Appavu, Snooks, Stulce, Rubin, Pate, Toney, Robertson, Wainwright, Roa, Schober and Slomine..
Introduction: Hospitalized children diagnosed with SARS-CoV-2-related conditions are at risk for new or persistent symptoms and functional impairments. Our objective was to analyze post-hospital symptoms, healthcare utilization, and outcomes of children previously hospitalized and diagnosed with acute SARS-CoV-2 infection or Multisystem Inflammatory Syndrome in Children (MIS-C).
Methods: Prospective, multicenter electronic survey of parents of children <18 years of age surviving hospitalization from 12 U.S. centers between January 2020 and July 2021. The primary outcome was a parent report of child recovery status at the time of the survey (recovered vs. not recovered). Secondary outcomes included new or persistent symptoms, readmissions, and health-related quality of life. Multivariable backward stepwise logistic regression was performed for the association of patient, disease, laboratory, and treatment variables with recovered status.
Results: The children [n = 79; 30 (38.0%) female] with acute SARS-CoV-2 (75.7%) or MIS-C (24.3%) had a median age of 6.5 years (interquartile range 2.0-13.0) and 51 (64.6%) had a preexisting condition. Fifty children (63.3%) required critical care. One-third [23/79 (29.1%)] were not recovered at follow-up [43 (31, 54) months post-discharge]. Admission C-reactive protein levels were higher in children not recovered vs. recovered [5.7 (1.3, 25.1) vs. 1.3 (0.4, 6.3) mg/dl, p = 0.02]. At follow-up, 67% overall had new or persistent symptoms. The most common symptoms were fatigue (37%), weakness (25%), and headache (24%), all with frequencies higher in children not recovered. Forty percent had at least one return emergency visit and 24% had a hospital readmission. Recovered status was associated with better total HRQOL [87 (77, 95) vs. 77 (51, 83), p = 0.01]. In multivariable analysis, lower admission C-reactive protein [odds ratio 0.90 (95% confidence interval 0.82, 0.99)] and higher admission lymphocyte count [1.001 (1.0002, 1.002)] were associated with recovered status.
Conclusions: Children considered recovered by their parents following hospitalization with SARS-CoV-2-related conditions had less symptom frequency and better HRQOL than those reported as not recovered. Increased inflammation and lower lymphocyte count on hospital admission may help to identify children needing longitudinal, multidisciplinary care.
Clinical Trial Registration: ClinicalTrials.gov (NCT04379089).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Frontiers in pediatrics - 12(2024) vom: 16., Seite 1340385 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fink, Ericka L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Child development |
|---|
| Anmerkungen: |
Date Revised 29.02.2024 published: Electronic-eCollection ClinicalTrials.gov: NCT04379089 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fped.2024.1340385 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369007212 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369007212 | ||
| 003 | DE-627 | ||
| 005 | 20240229235306.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fped.2024.1340385 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM369007212 | ||
| 035 | |a (NLM)38410766 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fink, Ericka L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Post-discharge outcomes of hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ClinicalTrials.gov: NCT04379089 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 Fink, Alcamo, Lovett, Hartman, Williams, Garcia, Rasmussen, Pal, Drury, MackDiaz, Ferrazzano, Dervan, Appavu, Snooks, Stulce, Rubin, Pate, Toney, Robertson, Wainwright, Roa, Schober and Slomine. | ||
| 520 | |a Introduction: Hospitalized children diagnosed with SARS-CoV-2-related conditions are at risk for new or persistent symptoms and functional impairments. Our objective was to analyze post-hospital symptoms, healthcare utilization, and outcomes of children previously hospitalized and diagnosed with acute SARS-CoV-2 infection or Multisystem Inflammatory Syndrome in Children (MIS-C) | ||
| 520 | |a Methods: Prospective, multicenter electronic survey of parents of children <18 years of age surviving hospitalization from 12 U.S. centers between January 2020 and July 2021. The primary outcome was a parent report of child recovery status at the time of the survey (recovered vs. not recovered). Secondary outcomes included new or persistent symptoms, readmissions, and health-related quality of life. Multivariable backward stepwise logistic regression was performed for the association of patient, disease, laboratory, and treatment variables with recovered status | ||
| 520 | |a Results: The children [n = 79; 30 (38.0%) female] with acute SARS-CoV-2 (75.7%) or MIS-C (24.3%) had a median age of 6.5 years (interquartile range 2.0-13.0) and 51 (64.6%) had a preexisting condition. Fifty children (63.3%) required critical care. One-third [23/79 (29.1%)] were not recovered at follow-up [43 (31, 54) months post-discharge]. Admission C-reactive protein levels were higher in children not recovered vs. recovered [5.7 (1.3, 25.1) vs. 1.3 (0.4, 6.3) mg/dl, p = 0.02]. At follow-up, 67% overall had new or persistent symptoms. The most common symptoms were fatigue (37%), weakness (25%), and headache (24%), all with frequencies higher in children not recovered. Forty percent had at least one return emergency visit and 24% had a hospital readmission. Recovered status was associated with better total HRQOL [87 (77, 95) vs. 77 (51, 83), p = 0.01]. In multivariable analysis, lower admission C-reactive protein [odds ratio 0.90 (95% confidence interval 0.82, 0.99)] and higher admission lymphocyte count [1.001 (1.0002, 1.002)] were associated with recovered status | ||
| 520 | |a Conclusions: Children considered recovered by their parents following hospitalization with SARS-CoV-2-related conditions had less symptom frequency and better HRQOL than those reported as not recovered. Increased inflammation and lower lymphocyte count on hospital admission may help to identify children needing longitudinal, multidisciplinary care | ||
| 520 | |a Clinical Trial Registration: ClinicalTrials.gov (NCT04379089) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a child development | |
| 650 | 4 | |a patient outcome assessment | |
| 650 | 4 | |a pediatrics | |
| 650 | 4 | |a post-acute COVID-19 syndrome | |
| 700 | 1 | |a Alcamo, Alicia M |e verfasserin |4 aut | |
| 700 | 1 | |a Lovett, Marlina |e verfasserin |4 aut | |
| 700 | 1 | |a Hartman, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Cydni |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Rasmussen, Lindsey |e verfasserin |4 aut | |
| 700 | 1 | |a Pal, Ria |e verfasserin |4 aut | |
| 700 | 1 | |a Drury, Kurt |e verfasserin |4 aut | |
| 700 | 1 | |a MackDiaz, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrazzano, Peter A |e verfasserin |4 aut | |
| 700 | 1 | |a Dervan, Leslie |e verfasserin |4 aut | |
| 700 | 1 | |a Appavu, Brain |e verfasserin |4 aut | |
| 700 | 1 | |a Snooks, Kellie |e verfasserin |4 aut | |
| 700 | 1 | |a Stulce, Casey |e verfasserin |4 aut | |
| 700 | 1 | |a Rubin, Pamela |e verfasserin |4 aut | |
| 700 | 1 | |a Pate, Bianca |e verfasserin |4 aut | |
| 700 | 1 | |a Toney, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Robertson, Courtney L |e verfasserin |4 aut | |
| 700 | 1 | |a Wainwright, Mark S |e verfasserin |4 aut | |
| 700 | 1 | |a Roa, Juan D |e verfasserin |4 aut | |
| 700 | 1 | |a Schober, Michelle E |e verfasserin |4 aut | |
| 700 | 1 | |a Slomine, Beth S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pediatrics |d 2013 |g 12(2024) vom: 16., Seite 1340385 |w (DE-627)NLM234254327 |x 2296-2360 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2024 |g day:16 |g pages:1340385 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fped.2024.1340385 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2024 |b 16 |h 1340385 | ||